Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A Breakthrough Mucoadhesive 3D-Printed Delivery System to Treat Oral Mucositis in Cancer Patients

Project description

Precision medicine tools for enhanced oral health in cancer patients

Cancer treatments often cause oral mucositis, a painful condition characterised by inflamed mouth ulcers that currently lacks effective cures. Affecting up to 90 % of radiotherapy patients, it severely compromises daily life and increases infection risks. Supported by the Marie Skłodowska-Curie Actions programme, the ADHESYS project will address this by developing a nature-based, mucoadhesive film for targeted, long-lasting therapeutic action. This tool will use bioactive polyphenols extracted from sustainable chokeberry waste, which will be encapsulated and 3D-printed to ensure efficacy. Unlike conventional treatments, this patient-tailored approach is expected to deliver synergistic antioxidant and anti-inflammatory effects directly to affected areas. By promoting faster healing, ADHESYS aims to reduce healthcare costs and significantly enhance the quality of life for millions of cancer patients worldwide.

Objective

Oral mucositis (OM) is one of the most frequent and debilitating side effects of cancer therapy, characterised by persistent inflammation, painful intraoral lesions and ulcers, impaired nutrition, and increased infection risk. It affects about 50% of patients receiving chemotherapy and up to 90% of those undergoing radiotherapy, significantly compromising their daily lives and contributing to substantial healthcare costs, often exceeding several thousand euros per patient. Despite its prevalence, no effective treatments currently exist. Conventional drug delivery systems are not able to treat cancer therapy-induced OM since they are not multi-targeted and their retention time in the oral cavity is too short.
Supported by the Marie Skłodowska-Curie Actions programme, ADHESYS redefines an innovative therapeutic option for supportive cancer care. The project aims to produce and characterize a nature-based mucoadhesive film that provides targeted and long-lasting pro-healing effects, thus moving beyond mere symptomatic relief. The film will incorporate nanoencapsulated bioactive polyphenols extracted from Aronia melanocarpa pomace, a sustainable food by-product of the juice industry. Engineered using only natural and biocompatible materials, the film will be fabricated via semisolid extrusion 3D-printing, offering superior reproducibility, commercial scalability, and a patient-tailored design compared to conventional film manufacturing methods. By co-delivering multiple bioactive polyphenols with synergistic antioxidant, anti-inflammatory, and wound healing effects directly to the affected area, this unique precision-medicine tool will promote OM healing, thus enhancing the oral health and quality of life of millions of cancer patients worldwide.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

UNIVERSITETET I OSLO
Net EU contribution
€ 251 578,56
Address
PROBLEMVEIEN 5-7
0313 Oslo
Norway
Region
Norge Oslo og Viken Oslo
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)